Insulet | PODD - Pasivo Circulante





Pasivo Circulante Cambio Fecha
Abbott USD 16.15B 1.66B 2026-09
Align Technology USD 1.91B 4.9M 2026-09
AtriCure USD 83.97M 2.06M 2026-09
Baxter International USD 3.81B 218M 2026-09
Becton, Dickinson and Co. USD 9.54B 139M 2026-09
Boston Scientific USD 5.98B 446M 2026-09
Cardinal Health USD 46.33B 2.42B 2026-09
Cooper Companies USD 1.87B 61.9M 2026-06
Dexcom USD 2.25B 105.1M 2026-09
Edwards Lifesciences USD 1.58B 68.8M 2026-09
Eli Lilly USD 47B 745M 2026-09
Globus Medical USD 507.94M 28.59M 2026-09
ICU Medical USD 514.63M 16.27M 2026-09
Inogen USD 64.94M 2.12M 2025-09
Insulet USD 814.4M 70.2M 2026-09
Integra LifeSciences USD 329M 1.88M 2026-09
J&J USD 55.46B 562M 2026-09
Medtronic USD 11.8B 141M 2026-06
Merit Medical Systems USD 265.08M 150K 2026-09
Roche Holding CHF 28.85B 846M 2026-06
Solventum Corp USD 3.58B 88M 2026-09
Stryker USD 6.5B 184M 2026-09
Tandem Diabetes Care USD 256.08M 3.07M 2026-09
Teleflex USD 917.1M 196.72M 2026-09
West Pharmaceutical Services USD 644.3M 3.8M 2026-09
Zimmer Biomet Holdings USD 3.5B 488.9M 2026-09